The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironment.
about
The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironment.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
The MEK inhibitor selumetinib ...... tumor immune microenvironment.
@en
type
label
The MEK inhibitor selumetinib ...... tumor immune microenvironment.
@en
prefLabel
The MEK inhibitor selumetinib ...... tumor immune microenvironment.
@en
P2093
P2860
P1476
The MEK inhibitor selumetinib ...... tumor immune microenvironment.
@en
P2093
Alwin Schuller
Amanda Watkins
Corrine Reimer
Edmund Poon
Geoffrey S Williams
Gianfranco Di Genova
Jens-Oliver Koopmann
Margaret Veldman-Jones
Marie Cumberbatch
Paul D Smith
P2860
P2888
P356
10.1186/S40425-017-0268-8
P577
2017-08-15T00:00:00Z
P6179
1090885833